Navigation Links
Progen Investor Teleconference Dial In Details
Date:2/4/2008

BRISBANE, Australia, Feb. 4 /PRNewswire-FirstCall/ -- Progen Pharmaceuticals' Management Team (ASX: PGL; Nasdaq: PGLA) will be conducting an investor teleconference on Tuesday 5 February at 9.00am Australian (Sydney time) and Monday 4 February at 5:00pm US EST.

The Management Team will present an overview of the Cellgate, Inc. acquisition and will be available to answer your queries.
Please refer to the relevant presentation at: http://www.progen-pharma.com

Please follow the dial-in instructions below:

National toll free - Australia - 1800 701 269

Country International Time of Teleconference call

toll free numbers: in the relevant locations

United Kingdom 1080 0264 0084 Monday, 4 February 2008 at 10:00 PM

Hong Kong 800 968 831 Tuesday, 5 February 2008 at 6:00 AM

Japan 0053 125 0068 Tuesday, 5 February 2008 at 7:00 AM

Singapore 800 616 3092 Tuesday, 5 February 2008 at 6:00 AM

Taiwan 008 0161 5152 Tuesday, 5 February 2008 at 6:00 AM

New Zealand 080 044 6041 Tuesday, 5 February 2008 at 11:00 AM

USA 1866 2421 388 Monday, 4 February at 2.00 PM PST

Monday, 4 February at 5.00 PM EST

International toll - + 61 2 8823 6760

Then dial conference identification number: 33563946

If your country is not listed, and you would like to participate on the call, please contact Cindy Ingram on +61 7 3842 3333 or cindyi@progen- pharma.com and she will provide you with the appropriate toll free number.

About Progen: Progen Pharmaceuticals Limited is an Australia-based globally focused biotechnology company committed to the discovery, development and commercialization of small molecule therapeutics primarily for the treatment of cancer.


'/>"/>
SOURCE Progen Pharmaceuticals Limited
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Elusive pancreatic progenitor cells found in mice
2. Imaging neural progenitor cells in the living human brain
3. Progen Update on Phase 3 Clinical Program for PI-88 in Liver Cancer
4. Progen to Present Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases
5. American Pacific to Release Financial Results and Hold Fiscal 2008 First Quarter Investor Teleconference
6. Stryker to Present at Investor Conference
7. The Advisory Board Company Schedules Third Quarter Investor Conference Call for February 5, 2008
8. GSI to Present at Upcoming Investor Growth Conferences
9. WebMD to Present at Upcoming Investor Conferences
10. Immtech Investor Conference Call Scheduled for January 3, 2008, at 1 PM
11. Mindray to Attend 2008 CLSA Asia Investors Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/19/2017)... ... 2017 , ... "At your fingertips" electronic access to patient ... Delaware Health Information Network (DHIN) have partnered to improve connectivity of this data ... exchange, DHIN stores and shares real-time health data for more than 2 million ...
(Date:2/18/2017)... ... February 17, 2017 , ... Focused start-ups, ... in the industry, according to the recent NEJM Catalyst Insights Report on the ... the NEJM Catalyst Insights Council, a qualified group of U.S. executives, clinical leaders, ...
(Date:2/18/2017)... ... February 17, 2017 , ... Park Cities Pet Sitter ... Show on the Pet Life Radio network. The episode, which was posted this ... topics including: what factors led to Park Cities Pet Sitter’s being awarded the 2017 ...
(Date:2/17/2017)... ... February 17, 2017 , ... Smiles by Seese is a ... Davidson, NC. Dr. Brian Seese leads the practice as a skilled and highly credentialed ... roof. Smiles by Seese serves patients of all ages with excellence in general, restorative, ...
(Date:2/17/2017)... ... February 17, 2017 , ... Wells Pharmacy Network ... prescribing of controlled and non-controlled substances plus the ability to manage orders on ... United States now accept electronic prescriptions, according to the Office of the National ...
Breaking Medicine News(10 mins):
(Date:2/20/2017)... 2017 Provides understanding and access to ... into by the worlds leading healthcare companies. ... Description The Global Renal Failure Partnering Terms and ... to partnering deals and agreements entered into by ... Trends in partnering deals - Top deals ...
(Date:2/20/2017)... 20, 2017 The report analyzes the worldwide markets for Drug-Eluting ... the US, Canada , Japan ... Latin America , and Rest of World. ... ... provided for the period 2015 through 2022. Also, a six-year historic ...
(Date:2/20/2017)... Feb. 20, 2017 This report analyzes the worldwide ... report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , and Rest ... http://www.reportlinker.com/p04707131-summary/view-report.html Annual estimates and forecasts are provided ... analysis is provided for these markets. Market data and analytics ...
Breaking Medicine Technology: